{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:23:31Z","timestamp":1773699811892,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":3134,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/06879-4"],"award-info":[{"award-number":["2013\/06879-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2010\/09497-7"],"award-info":[{"award-number":["2010\/09497-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2012\/08654-7"],"award-info":[{"award-number":["2012\/08654-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2012\/01936-7"],"award-info":[{"award-number":["2012\/01936-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/21066-2"],"award-info":[{"award-number":["2014\/21066-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1017\/s1041610215001842","type":"journal-article","created":{"date-parts":[[2015,11,11]],"date-time":"2015-11-11T04:41:49Z","timestamp":1447216909000},"page":"939-944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Serotoninergic antidepressants positively affect platelet ADAM10 expression in patients with Alzheimer's disease"],"prefix":"10.1016","volume":"28","author":[{"given":"Ot\u00e1vio Augusto Fernandes Marques","family":"Bianco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia Regina","family":"Manzine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla Manuela Crispim","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Assis Carvalho","family":"Vale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia Cristina Iost","family":"Pavarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcia Regina","family":"Cominetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610215001842_bb0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0006-8993(02)03153-0","article-title":"Effect of a 5-HT(2C) serotonin agonist, dexnorfenfluramine, on amyloid precursor protein metabolism in guinea pigs","volume":"951","author":"Arjona","year":"2002","journal-title":"Brain Research"},{"key":"10.1017\/S1041610215001842_bb0015","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.2174\/092986707782360060","article-title":"Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's disease","volume":"14","author":"Bandyopadhyay","year":"2007","journal-title":"Current Medicinal Chemistry"},{"key":"10.1017\/S1041610215001842_bb0020","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.neurobiolaging.2013.08.028","article-title":"Nardilysin, ADAM10, and Alzheimer's disease: of mice and men","volume":"35","author":"Bernstein","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1017\/S1041610215001842_bb0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coph.2011.01.012","article-title":"5-HT(4) receptors, a place in the sun: act two","volume":"11","author":"Bockaert","year":"2011","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1017\/S1041610215001842_bb0030","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1590\/S0004-282X2003000500014","article-title":"Suggestions for utilization of the mini-mental state examination in Brazil","volume":"61","author":"Brucki","year":"2003","journal-title":"Arquives of Neuropsiquiatry"},{"key":"10.1017\/S1041610215001842_bb0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2009.10.022","article-title":"Depression and Alzheimer's disease: neurobiological links and common pharmacological targets","volume":"626","author":"Caraci","year":"2010","journal-title":"European Journal of Pharmacology"},{"key":"10.1017\/S1041610215001842_bb0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/1567205012666150204124310","article-title":"The prevalence of depression in Alzheimer's disease: a systematic review and meta-analysis","volume":"12","author":"Chi","year":"2015","journal-title":"Current Alzheimer Research"},{"key":"10.1017\/S1041610215001842_bb0045","doi-asserted-by":"crossref","first-page":"14968","DOI":"10.1073\/pnas.1107411108","article-title":"Serotonin signaling is associated with lower amyloid-beta levels and plaques in transgenic mice and humans","volume":"108","author":"Cirrito","year":"2011","journal-title":"Proceedings of Natural Academy of Science USA"},{"key":"10.1017\/S1041610215001842_bb0050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1021\/cn300095t","article-title":"5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10","volume":"4","author":"Cochet","year":"2013","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1017\/S1041610215001842_bb0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF03402076","article-title":"[alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients","volume":"8","author":"Colciaghi","year":"2002","journal-title":"Molecular Medicine"},{"key":"10.1017\/S1041610215001842_bb0060","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/01.WNL.0000106953.49802.9C","article-title":"Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease","volume":"62","author":"Colciaghi","year":"2004","journal-title":"Neurology"},{"key":"10.1017\/S1041610215001842_bb0065","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1460-9568.2010.07461.x","article-title":"The close link between retinoid signalling and the alpha-secretase ADAM10 and its potential for treating Alzheimer's disease (commentary on Jarvis et al.)","volume":"32","author":"Fahrenholz","year":"2010","journal-title":"European Journal of Neuroscience"},{"key":"10.1017\/S1041610215001842_bb0070","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1017\/S1041610215001842_bb0075","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1017\/S1041610215001842_bb0080","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/gps.4020","article-title":"Platelet a disintegrin and metallopeptidase 10 expression correlates with clock drawing test scores in Alzheimer's disease","volume":"29","author":"Manzine","year":"2014","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610215001842_bb0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-130125","article-title":"Correlation between mini-mental state examination and platelet ADAM10 expression in Alzheimer's disease","volume":"36","author":"Manzine","year":"2013","journal-title":"Journal of Alzheimers Disease"},{"key":"10.1017\/S1041610215001842_bb0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000345983","article-title":"ADAM10 as a biomarker for Alzheimer's disease: a study with Brazilian elderly","volume":"35","author":"Manzine","year":"2013","journal-title":"Dementia and Geriatriatic Cognitive Disorders"},{"key":"10.1017\/S1041610215001842_bb0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/1354750X.2015.1062554","article-title":"ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects","volume":"20","author":"Manzine","year":"2015","journal-title":"Biomarkers"},{"key":"10.1017\/S1041610215001842_bb0100","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1017\/S1041610215001842_bb0105","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1590\/S0034-89102005000600007","article-title":"[Validity of the Portuguese version of Clinical Dementia Rating]","volume":"39","author":"Montano","year":"2005","journal-title":"Revista de Saude Publica"},{"key":"10.1017\/S1041610215001842_bb0110","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.expneurol.2007.01.037","article-title":"Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice","volume":"205","author":"Nelson","year":"2007","journal-title":"Experimental Neurology"},{"issue":"Suppl. 1","key":"10.1017\/S1041610215001842_bb0115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1471-4159.2011.07459.x","article-title":"Activation of alpha-secretase cleavage","volume":"120","author":"Postina","year":"2012","journal-title":"Journal of Neurochemistry"},{"key":"10.1017\/S1041610215001842_bb0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1017\/S1041610209990184","article-title":"Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors","volume":"22","author":"Rozzini","year":"2010","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610215001842_bb0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuropharm.2011.02.026","article-title":"5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment","volume":"61","author":"Shen","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1017\/S1041610215001842_bb0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrn2977","article-title":"The role of G protein-coupled receptors in the pathology of Alzheimer's disease","volume":"12","author":"Thathiah","year":"2011","journal-title":"Nature Reviews Neuroscience"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104161022400824X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104161022400824X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610215001842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T04:54:22Z","timestamp":1754974462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104161022400824X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S104161022400824X"],"URL":"https:\/\/doi.org\/10.1017\/s1041610215001842","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serotoninergic antidepressants positively affect platelet ADAM10 expression in patients with Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610215001842","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}